Study of Hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal dissemination and appendiceal mucinous neoplasm

Not Applicable

• Conditions: peritoneal dissemination and appendiceal mucinous neoplasm

• Registration Number: JPRN-UMIN000016360
• Lead Sponsor: Mie university gastrointestinal and pediatric surgery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-01-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Open public recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

?Patients with peritoneal metastasis of gastric cancer,colon cancer, or appendicecal mucosal neoplasm
?Patients with positive peritoneal cytology
?Except for cases having distant metastasis such as liver and lung, and cases having non-healing factor such as unresectable lymph node metastasis except for peritoneal metastasis

Exclusion Criteria

?Patients with heart disease(Arrhythmia requiring acute myocardial infarction within 6 months after the onset of ischemic heart disease, a medical treatment)
?Patients with a history of cerebrovascular disorder of cerebral infarction, cerebral hemorrhage, etc.
?Patients of systolic blood pressure less than 80mmHg or hypotension
?During pregnancy, Women suspected of being pregnant and Lactating woman
?Patients with dementia
?Patients with a history of shock during extracorporeal circulation therapy
?Patients taking stop angiotensin converting enzyme inhibitors, is difficult prior to extracorporeal circulation therapy
?Patients admitted unsuitable for the clinical study by research investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified